BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9827924)

  • 21. T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases.
    Hu Z; Medeiros LJ; Xu M; Yuan J; Peker D; Shao L; Tang Z; Mai B; Thakral B; Rios A; Hu S; Wang W
    Am J Clin Pathol; 2023 Apr; 159(4):325-336. PubMed ID: 36883805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia.
    Hu Z; Medeiros LJ; Fang L; Sun Y; Tang Z; Tang G; Sun T; Quesada AE; Hu S; Wang SA; Pei L; Lu X
    Am J Hematol; 2017 May; 92(5):441-447. PubMed ID: 28194886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia.
    Ruchlemer R; Parry-Jones N; Brito-Babapulle V; Attolico I; Wotherspoon AC; Matutes E; Catovsky D
    Br J Haematol; 2004 May; 125(3):330-6. PubMed ID: 15086413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
    Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
    J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of prolymphocytic leukemia.
    Dearden C
    Hematology Am Soc Hematol Educ Program; 2015; 2015():361-7. PubMed ID: 26637744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell prolymphocytic leukemia: update and focus on alemtuzumab (Campath-1H).
    Cao TM; Coutre SE
    Hematology; 2003 Feb; 8(1):1-6. PubMed ID: 12623420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case report of T cell prolymphocytic leukemia and Kaposi sarcoma and a review of T cell prolymphocytic leukemia.
    Paul RN; Alizadeh L; Ajayi OI; Karpurapu H; Ganesan C; Taddesse-Heath L; Aggarwal A
    Acta Haematol; 2012; 127(4):235-43. PubMed ID: 22517037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple karyotypic abnormalities in three cases of small cell variant of T-cell prolymphocytic leukemia.
    Heinonen K; Mahlamäki E; Hämäläinen E; Nousiainen T; Mononen I
    Cancer Genet Cytogenet; 1994 Nov; 78(1):28-35. PubMed ID: 7987802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia.
    López C; Bergmann AK; Paul U; Murga Penas EM; Nagel I; Betts MJ; Johansson P; Ritgen M; Baumann T; Aymerich M; Jayne S; Russell RB; Campo E; Dyer MJ; Dürig J; Siebert R
    Br J Haematol; 2016 Apr; 173(2):265-73. PubMed ID: 26917488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined immunophenotyping and karyotyping in peripheral T cell lymphomas demonstrating different clonal and nonclonal chromosome aberrations in T helper cells.
    Schlegelberger B; Weber-Matthiesen K; Sterry W; Bartels H; Sonnen R; Maschmeyer G; Feller AC; Grote W
    Leuk Lymphoma; 1994 Sep; 15(1-2):113-25. PubMed ID: 7858488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged survival in two cases of T-prolymphocytic leukemias with complex hypodiploid chromosomal abnormalities.
    Yokohama A; Karasawa M; Takada S; Matsushima T; Murakami H; Miyao S; Sato S; Naruse T
    J Med; 2000; 31(3-4):183-94. PubMed ID: 11280450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell prolymphocytic leukemia in Japan: is it a variant?
    Kameoka J; Takahashi N; Noji H; Murai K; Tajima K; Kameoka Y; Sato S; Shichishima T; Ishida Y; Harigae H; Sawada K
    Int J Hematol; 2012 Jun; 95(6):660-7. PubMed ID: 22527853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engraftment of chronic prolymphocytic and T cell leukemia in SCID mice.
    O'Brien S; Jeha S; Kantarjian H; Pisa P; Jin G; Keating M; Beran M
    Leukemia; 1996 Feb; 10(2):338-44. PubMed ID: 8637244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic characterization of T-PLL reveals two major biologic subgroups and JAK3 mutations as prognostic marker.
    Stengel A; Kern W; Zenger M; Perglerová K; Schnittger S; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2016 Jan; 55(1):82-94. PubMed ID: 26493028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of T leukaemias with cerebriform nuclei to T-prolymphocytic leukaemia: a cytogenetic analysis with in situ hybridization.
    Brito-Babapulle V; Maljaie SH; Matutes E; Hedges M; Yuille M; Catovsky D
    Br J Haematol; 1997 Mar; 96(4):724-32. PubMed ID: 9074412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell prolymphocytic leukemia: a single-institution experience.
    Ravandi F; O'Brien S; Jones D; Lerner S; Faderl S; Ferrajoli A; Wierda W; Garcia-Manero G; Thomas D; Koller C; Verstovsek S; Giles F; Cortes J; Herling M; Kantarjian H; Keating M
    Clin Lymphoma Myeloma; 2005 Nov; 6(3):234-9. PubMed ID: 16354329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicentric study of 41 cases of B-prolymphocytic leukemia: two evolutive forms.
    Hercher C; Robain M; Davi F; Garand R; Flandrin G; Valensi F; Vandeputte H; Albert A; Maynadie M; Troussard X; Simon GH; Lespinasse J; Portefaix G; Merle-Beral H;
    Leuk Lymphoma; 2001; 42(5):981-7. PubMed ID: 11697653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course.
    Put N; Van Roosbroeck K; Konings P; Meeus P; Brusselmans C; Rack K; Gervais C; Nguyen-Khac F; Chapiro E; Radford-Weiss I; Struski S; Dastugue N; Gachard N; Lefebvre C; Barin C; Eclache V; Fert-Ferrer S; Laibe S; Mozziconacci MJ; Quilichini B; Poirel HA; Wlodarska I; Hagemeijer A; Moreau Y; Vandenberghe P; Michaux L;
    Ann Hematol; 2012 Jun; 91(6):863-73. PubMed ID: 22205151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32).
    Dürig J; Bug S; Klein-Hitpass L; Boes T; Jöns T; Martin-Subero JI; Harder L; Baudis M; Dührsen U; Siebert R
    Leukemia; 2007 Oct; 21(10):2153-63. PubMed ID: 17713554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia.
    Brito-Babapulle V; Pittman S; Melo JV; Pomfret M; Catovsky D
    Hematol Pathol; 1987; 1(1):27-33. PubMed ID: 3509770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.